SAR by MS: Discovery of a New Class of RNA-Binding Small Molecules for the Hepatitis C Virus: Internal Ribosome Entry Site IIA Subdomain
Punit P. Seth(Ionis Pharmaceuticals (United States)), Richard H. Griffey(Leidos (United States)), Rangarajan Sampath(Analytical Services), Stephen A. Osgood(Ionis Pharmaceuticals (United States)), Elizabeth A. Jefferson(Ionis Pharmaceuticals (United States)), Alycia Miyaji(Ionis Pharmaceuticals (United States)), Christian Massire(Ionis Pharmaceuticals (United States)), Stephanie Propp(Ionis Pharmaceuticals (United States)), Kristin A. Sannes‐Lowery(Ionis Pharmaceuticals (United States)), Ray Ranken(Ionis Pharmaceuticals (United States)), David J. Ecker(University of Colorado Denver), Eric E. Swayze(Ionis Pharmaceuticals (United States))
Cited by 174
Related Papers
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
|Cell Metabolism|2006|2.1k
A Multiubiquitin Chain Is Confined to Specific Lysine in a Targeted Short-Lived Protein
|Science|1989|1.5k
Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary<i>N</i>-acetyl galactosamine improves potency 10-fold in mice
|Nucleic Acids Research|2014|594
Analysis of Antibiotic Resistance Genes in Multidrug-Resistant <i>Acinetobacter</i> sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center
|Antimicrobial Agents and Chemotherapy|2006|481
Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals
|Nucleic Acids Research|2006|461